Non-pharmacological Treatment of Patients at Risk of Developing Persistent Posttraumatic Headache

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorEsbjerg Hospital - University Hospital of Southern Denmark

About this trial

The goal of this mixed method study is to test and evaluate the effect of an early interdisciplinary non-pharmacological treatment of patients at risk of developing persistent posttraumatic headache in order to prevent the development of persistent posttraumatic headache and thereby, reduce persistency and improve the quality of life. Furthermore, to gain knowledge on and a deeper understanding of the patients' perspective and experience of the treatment.

The project consists of 3 sub studies:

1. A feasibility study; with the purpose of exploring the feasibility of an early non-pharmacological intervention for patients with persistent posttraumatic headache after mild traumatic brain injury. 2. An experimental design; a randomized controlled trial to evaluate the effect of the early non-pharmacological treatment. 3. A qualitative focus group interview study; to get a more nuanced knowledge of patients' experience with the non-pharmacological treatment related to post traumatic headache.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical diagnosed with acute posttraumatic headache

Headache present for more than 15 days/month

Must understand written and spoken Danish

Disqualifiers

History of pre-existing primary or secondary headache

Dementia or comorbidity with neurological disorders

Psychiatric disorders

Participants who cannot collaborate in relation to the intervention

Trial design

Design model

Parallel

Treatments tested in this trial

  • The intervention group

    Behavioral

    Is described in arm

Treatment groups

104 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of days with headache within the last week

The primary outcome is number of days with headache within the last week. Headache will be reported by a self-administered validated headache diary. Patients note every day if they experience any headache. The diary assesses days with headache graduated in intensity using a 1-3 scale (1= mild intensity and 3= severe intensity).

Time frame
8 months

Secondary outcomes

1

Headache intensity

Secondary outcomes measures are headache intensity during the last 24 hours and intensity during the last week evaluated using a numeric rating scale. Two questions will be posed: "On a scale from 0 (equals no pain) to 10 (worst imaginable pain), please specify the degree of pain due to headache during the last 24 hours and "On a scale from 0 (equals no pain) to 10 (worst imaginable pain), please specify the degree of pain due to headache during the last week?"

Time frame
8 months
2

Headache disability

To measure the severity of headache the Headache Impact Test (HIT6) is used. The questionnaire is a reliable and validated tool used to measure how big an impact headache has on patients' ability to function at work, at school, at home and in social relations.

Time frame
8 months
3

Coping strategies

Coping strategies, will be measured by the Coping strategy Questionnaire (CSQ). The validated questionnaire includes six coping strategy subscales: Ignoring pain, reinterpretation of pain, diverting attention, coping self-statements, catastrophizing, praying/hoping, and two subscales for behavioral strategies: Increasing activity levels and increasing pain behaviors.

Time frame
8 months
4

Mental health

Mental health will be measured by The 36-item Short Form Survey (SF-36).This is a reliable and validated instrument frequently used across different patient groups. The instrument consists of 36 items on perceived health-related quality of life, with answers divided into eight scales measuring health concepts: physical functioning, role physical, role emotional, social functioning, bodily pain, mental health, vitality and general health. All eight scales contribute in different proportions to the scoring of both physical and mental measures.

Time frame
8 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Esbjerg Hospital - University Hospital of Southern Denmark

Lead sponsor

Region of Southern Denmark

Collaborator

University of Southern Denmark

Collaborator

This trial is not recruiting at the moment. You can still explore other options: